争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 8 条
2024
2022
2021
2021
BTL与艾伯维达成专利纠纷和解
和解
BTL宣布已解决其针对艾伯维、涉及BTL肌肉刺激技术的专利侵权索赔。根据和解协议，艾伯维将向BTL支付未披露金额，双方未决诉讼将撤销。
来源摘录
Under the terms of the settlement agreement, ABBVIE will pay BTL an undisclosed payment.
BTL Industries—a leading manufacturer of innovative aesthetic products—announced today that the company has resolved its patent infringement claims against ABBVIE related to BTL's muscle stimulation technology.
2021
AbbVie 对 Alvotech 提起第二起诉讼
提起诉讼
AbbVie 在伊利诺伊州北区对 Alvotech hf. 提起第二起诉讼，指控其涉及 Alvotech 拟议的 HUMIRA 生物类似药的专利侵权。
来源摘录
On May 28, AbbVie brought a second action in the Northern District of Illinois for patent infringement against Alvotech hf. under the BPCIA in connection with Alvotech’s proposed biosimilar version of HUMIRA® (adalimumab).
2021
Alvotech 就 Humira 专利起诉 AbbVie
提起诉讼
Alvotech USA 与 Alvotech hf 在弗吉尼亚东区法院对 AbbVie 提起确认判决诉讼，指称 AbbVie Humira 专利组合中的专利无效或不可执行，并请求法院作出不侵权及专利无效的确认判决。
来源摘录
For each patent, the complaint asserts a claim for a declaratory judgment of non-infringement and invalidity.
On May 11, 2021, Alvotech USA and Alvotech hf (jointly, Alvotech) filed a complaint seeking declaratory judgement against AbbVie Inc. and AbbVie Biotechnology Ltd (jointly, AbbVie) in the Eastern District of Virginia.
2020
2018